Center Laboratories
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antituss… Read more
Center Laboratories (4123) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.002x
Based on the latest financial reports, Center Laboratories (4123) has a cash flow conversion efficiency ratio of 0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$46.61 Million) by net assets (NT$19.64 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Center Laboratories - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Center Laboratories's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Center Laboratories Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Center Laboratories ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
|
0.409x |
|
Turkiye Sigorta AS
IS:TURSG
|
0.086x |
|
Shenzhen Jove Enterprise Co. Ltd.
SHE:300814
|
0.051x |
|
H2O Retailing Corporation
PINK:HTOCF
|
N/A |
|
Zhangjiagang Guangda Special Material Co Ltd
SHG:688186
|
-0.021x |
|
Zhejiang Jiangshan Chemical Co Ltd
SHE:002061
|
0.111x |
|
LMW Limited
NSE:LMW
|
N/A |
|
Warehouses de Pauw CVA S.C.A.
LSE:0MU2
|
0.018x |
Annual Cash Flow Conversion Efficiency for Center Laboratories (2006–2024)
The table below shows the annual cash flow conversion efficiency of Center Laboratories from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$18.05 Billion | NT$415.71 Million | 0.023x | +148.32% |
| 2023-12-31 | NT$20.22 Billion | NT$-963.44 Million | -0.048x | -383.21% |
| 2022-12-31 | NT$19.25 Billion | NT$-189.88 Million | -0.010x | +41.91% |
| 2021-12-31 | NT$21.09 Billion | NT$-358.14 Million | -0.017x | -29.96% |
| 2020-12-31 | NT$20.63 Billion | NT$-269.56 Million | -0.013x | +29.50% |
| 2019-12-31 | NT$15.46 Billion | NT$-286.45 Million | -0.019x | -146.39% |
| 2018-12-31 | NT$15.47 Billion | NT$617.84 Million | 0.040x | -66.54% |
| 2017-12-31 | NT$16.87 Billion | NT$2.01 Billion | 0.119x | +63.44% |
| 2016-12-31 | NT$15.82 Billion | NT$1.16 Billion | 0.073x | +886.07% |
| 2015-12-31 | NT$14.88 Billion | NT$-138.29 Million | -0.009x | -754.87% |
| 2014-12-31 | NT$6.94 Billion | NT$-7.54 Million | -0.001x | -113.13% |
| 2013-12-31 | NT$5.01 Billion | NT$41.50 Million | 0.008x | +77.01% |
| 2012-12-31 | NT$3.47 Billion | NT$16.23 Million | 0.005x | -85.23% |
| 2011-12-31 | NT$2.21 Billion | NT$70.11 Million | 0.032x | +1890.25% |
| 2010-12-31 | NT$2.18 Billion | NT$-3.86 Million | -0.002x | -109.56% |
| 2009-12-31 | NT$2.11 Billion | NT$39.11 Million | 0.019x | -76.35% |
| 2008-12-31 | NT$573.09 Million | NT$44.86 Million | 0.078x | -45.54% |
| 2007-12-31 | NT$471.17 Million | NT$67.71 Million | 0.144x | +1.12% |
| 2006-12-31 | NT$273.07 Million | NT$38.81 Million | 0.142x | -- |